AzTrials
AzTrials

Atrophy; BoneNCT05593198

Guided Bone Regeneration Versus Bone Block Grafting

A study testing Khoury technique and Guided bone regeneration in people with Atrophy; Bone, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to analyze the volumetric gain and stability of the newly formed bone tissue comparing guided bone regeneration with block graft. Read more about this study

Who is it for?
Ages 18 to 90 yearsHealthy volunteers can take part
Conditions the study is for
Atrophy; Bone
What is being tested?
Khoury technique and Guided bone regeneration
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
1 siteItaly
Study dates
1 Nov 2022to 2 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients in need of an implant-supported rehabilitation
  • Patients requiring bone regeneration
  • Healthy patients
  • Full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) ≤ 15%
  • Sufficient mesiodistal and interocclusal space
  • At least 6 months of follow-up

Who cannot join

  • An American Society of Anesthesiologists physical status classification ≥ III
  • General contraindications for surgical treatment or implant placement
  • Untreated periodontitis
  • Smoking
  • Excessive alcohol consumption
  • Any drug or medication known to affect oral status and bone turnover or contraindicate surgical treatment
  • No residual keratinized tissue at the experimental area
  • Unwillingness to return for follow-up examinations

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Fondazione Policlinico Gemelli

    Rome

Other trials in Italy

About this study

Official title: Randomized Controlled Clinical Trial Comparing the Clinical Measures and the Radiographical Volumetric Outcomes Assessed by Cone Beam Computed Tomography of Guided Bone Regeneration Versus Bone Block Grafting

The purpose of this study is to analyze the volumetric gain and stability of the newly formed bone tissue comparing guided bone regeneration with block graft.

Conditions
Atrophy; Bone
Being tested
Khoury technique, Guided bone regeneration
Keywords
Bone Regeneration
Medical subject headings
Atrophy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Khoury techniqueProcedure or surgery

    the bone block will be used following the principles of the Khoury technique to augment the bone volume.

  • Guided bone regenerationProcedure or surgery

    the membrane and the bone granules will be used to perform the guided bone regeneration technique.

Study groups in NCT05593198
Study groupRoleWhat they receive
Guided bone regenerationActive comparatorPatients will be treated with guided bone regeneration.
Receives: Procedure: Guided bone regeneration
Bone blockExperimentalPatients will be treated with bone blocks using the Khoury technique.
Receives: Procedure: Khoury technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bone volume

    the bone volume will be analyzed with the Cone Beam Computed Tomography scan

    Measured: 6 Months follow up

Secondary outcomes (3)
  1. Periodontal parameters

    the periodontal parameters will be analyzed clinically with the periodontal probe and measured in millimeters. All the periodontal parameters will be combined to describe the periodontal status of the patient.

    Measured: 6 Months follow up

  2. Wound healing

    the wound healing will be recorded with the Early Wound Healing Score (EHS) ranging from 0 to 10 which includes the following parameters:

    • clinical signs of re-epithelialization: 0 points, visible distance between incision margins; 3 points, incision margins in contact; 6 points, merged incision margins.
    • clinical signs of haemostasis: 0 points, bleeding at the incision margins; 1 point, presence of fibrin at the incision margins; 2 points, absence of fibrin on the incision margins.
    • clinical signs of inflammation: 0 points, redness involving >50% of the incision length and/or pronounced swelling; 1 point, redness involving <50% of the incision length; 2 points, absence of redness along the incision length.

    Measured: 2 weeks follow up

  3. Histological analysis

    The histological analysis will be performed harvesting a sample during the implant placement. Bone biopsies including both native and regenerated bone will be subjected to digital scanning to analyze the characteristics of newly formed bone, the remaining grafted material, integration of grafted material with newly formed bone, soft tissue, and local inflammation. Histomorphometric analyses will be performed to measure the following parameters: bone tissue area , graft material area , soft tissue area. Bone tissue area , graft material area , soft tissue area will be expressed relative to the total area.

    Measured: 6 Months follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2022
  2. Study start1 Nov 2022
  3. Primary completion1 Jul 2023
  4. Study completion2 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05593198
Sponsor's protocol ID
4729
Status last verified
Oct 2022
First submitted
5 Sep 2022
Last updated
29 Aug 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Khoury technique and Guided bone regeneration in people with Atrophy; Bone, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bone volume (time frame: 6 Months follow up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in